Galderma to buy US firm ZO Skin Health for $1.5 billion

ZURICH, Oct 14 (Reuters) – Swiss skincare firm Galderma has agreed to acquire US company ZO Skin Health for an enterprise value of $1.5 billion, it said on Wednesday, confirming a report published by

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)